Welcome to our dedicated page for Waldencast plc news (Ticker: WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast plc stock.
Waldencast plc (NASDAQ: WALD) is a global multi-brand beauty and wellness platform focused on developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company operates through two main segments: Obagi Skincare and Milk Makeup.
Obagi Skincare is renowned for its medical-grade skincare products that deliver transformative results. Recently, Obagi announced the appointment of Dr. Suzan Obagi as its first-ever Chief Medical Director. Dr. Obagi is a world-renowned dermatologist and cosmetic surgeon, bringing extensive expertise in aesthetic dermatology and skincare to the company. Under her leadership, Obagi aims to advance its product development, research initiatives, and educational programs. Notable products in the Obagi range include the Obagi Nu-Derm® System, Professional-C®, ELASTIderm®, and Obagi Nu-Cil™, addressing skin concerns like hyperpigmentation, fine lines, hydration, brightening, and acne.
Milk Makeup is another flagship brand under Waldencast, known for its innovative and inclusive beauty products. The brand emphasizes creativity and sustainability, appealing to a diverse range of consumers. Recently, Waldencast appointed Mazdack Rassi, Co-Founder of Milk Makeup, as the Global Brand Director. He will lead the newly formed Creative Council, focusing on future trends in beauty, wellness, and culture.
Waldencast's business model is brand-led, ensuring proximity to customers, agility, and responsiveness in the market while maintaining each brand’s unique identity. The company benefits from the operational scale of a multi-brand platform and the expertise in managing global beauty brands at scale. This approach allows Waldencast to mitigate category fluctuations and achieve asset-light efficiency.
Recent achievements include the launch of the Daily Hydro-Drops® Rejuvenating Eye Gel Cream by Obagi, offering a solution for dry skin around the eyes with 24-hour hydration. Furthermore, Waldencast's financial performance has shown promising growth, with a notable increase in gross profit for Q1 2024 compared to the previous year.
For more information, visit the company’s website: Waldencast Investor Relations.
Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results on Tuesday, May 21, 2024, before the U.S. stock market opens. The company will hold a conference call at 8:30am ET on the same day to discuss the results.
Investors and analysts can join the call by dialing (877) 704-4453, or (201) 389-0920 for international callers. The earnings call will also be webcast live on the company's investor relations website, where a replay will be available for 90 days.
Waldencast plc, a global multi-brand beauty and wellness platform, will participate in the CreatorIQ Connect Europe conference in London on May 2, 2024. Founder and CEO Michel Brousset will discuss building legacy brands with industry leaders. The event aims to explore creator marketing strategies in the beauty industry.
Waldencast plc reported a successful fiscal year 2023 with net revenue of $218.1 million, a 15.3% increase from 2022. Group combined comparable revenue reached $212.5 million, and adjusted EBITDA improved to $24.4 million. Obagi Skincare saw revenue growth excluding Southeast Asia, while Milk Makeup excelled with revenue of $100.5 million. The company expects a 20% growth in Q1 2024 and an expansion in adjusted EBITDA margin for FY2024.
FAQ
What is the current stock price of Waldencast plc (WALD)?
What is the market cap of Waldencast plc (WALD)?
What does Waldencast plc do?
What are the main segments of Waldencast plc?
Who is Dr. Suzan Obagi?
What is the role of Mazdack Rassi at Waldencast?
What are some notable products from Obagi Skincare?
What is unique about Milk Makeup?
How does Waldencast ensure brand uniqueness?
What recent product did Obagi launch?
How has Waldencast's financial performance been recently?
Where can I find more information about Waldencast?
